Activating two somatostatin receptors enhances amyloid beta breakdown and improves memory in models of Alzheimer’s disease.

The drug is called NU-9, and a team from Northwestern University in the US tested it on mouse models of Alzheimer's disease.

For decades, Alzheimer’s disease has been framed as a one‑way slide, with treatments aiming only to slow the descent. Now a ...

A younger person walks arm-in-arm with an older person at a care facility. (Geralt/Pixabay via Courthouse News) (CN) — In what was described as a breakthrough discovery, researchers at the Icahn ...

Amyloid beta deposits long known to build up in the brains of Alzheimer’s disease (AD) patients have been found to serve as a kind of scaffold for the accumulation of other proteins. Because many of ...

Researchers are slowly tossing much of what we've been told for many years about Alzheimer's disease out the window — and replacing what has been a very dreary tale with new findings.

Scientists reversed advanced Alzheimer's in mice using a compound that restores cellular energy. The breakthrough challenges ...

Alzheimer's disease affects the brain in tragic and seemingly irreversible ways, but a new study gives hope that its ...

More than 7 million Americans have Alzheimer's disease, and two-thirds of them are women, according to the Alzheimer's ...

New findings suggest sex-specific immune responses in Alzheimer’s, as female microglia show heightened interferon signaling ...